Bioactive peptides and proteins are derived from plant and animal sources and have numerous health benefits such as promoting antioxidant, antihypertensive, antibiotic, anticancer, or immunomodulatory activities in the body. From the animal source, they can be derived from dairy sub-segments, whey, casein, milk protein concentrate, egg & meat, gelatin, fish & insects, and seafood. from plant the source they can be extracted from plant segment, cereals (wheat, corn & others), legumes (soybean, pea), soy protein concentrates, soy protein isolates, textured soy protein, pseudo cereals, brasssicaceae species, and others (sunflower). They find application across functional food, functional beverages, dietary supplements, animal nutrition, and personal care products.
The bioactive protein and peptides market was estimated to account for US$ 43.3 billion in terms of revenue in 2018 and is predicted to grow at a CAGR of 8.2% during the forecast period (2019 to 2027).
Growing aging population base rate and incidence of chronic disease is predominantly fueling the market growth of bioactive peptides and proteins. According to IMF, 400 to 500 million people of the age group above 50 is having chronic or age-related problem due to lack of protein and vitamins in their body. This has increased consumer concern over protein consumption. As per Food and Agriculture Organization (FAO), global protein consumption amongst the world population has increased at a CAGR of 5.5% over the last five years (2010-2015). Therefore, rising consumption of proteins among the aging population is expected to foster market growth.
According to the Coherent Market Insights analysis, peptide manufacturer such as Cargill, Omega Protein, Gellita AG are focusing on producing peptides especially targeting applications such as blood pressure control, cholesterol-lowering, and heart energy. Thus, such an emerging application of protein in the medical industry is expected to offer lucrative growth opportunity to the manufacturer of global bioactive protein and peptides over the forecast period. Also, the growing application of bioactive peptide in the production of baby foods formula is further anticipated to foster market growth.
Issues associated with the extraction of bioactive protein and peptides as the process is complex is projected to restrict the market growth of bioactive protein and peptides. Precipitation and migration or flocculation are a major problem associated with the extraction process. These factors are resulting in price volatility, high storage costs, and less availability of raw materials for supplying to processing companies. Therefore, improper functioning of the supply chain is hampering the overall growth of the global bioactive protein and peptides market over the forecast period.
On the basis of source, animal source segment dominated the global bioactive protein and peptides market in 2018 with a 58.3% of market share in terms of revenue, followed by plant source. The rising trend of consumption of dairy based proteins, among consumers, is expected to foster the market growth in upcoming years.
The increasing focus of manufacturers to introduced bioactive protein-based beverages due to newly introduced branched amino acid and essential amino acid ingredients that can be used in protein drinks is projected to foster the market growth of bioactive peptides and proteins. These ingredients promote easier muscle development and reduce the pain after work out. For instance, in October 2019, Nestle owned Garden of Life brand, is expanding into the ready-to-drink segment with the introduction of two protein beverages. The brand is launching Garden of Life Organic Protein Plant-Based Drinks, which is made from plant-based protein and Garden of Life Sport Protein Drinks- made with grass-fed dairy protein.
The growing interest of manufacture to introduce bioactive for the cosmetic industry in order to fulfill the rising demand for a cosmetic product is expected to propel the market growth over the forecast period. For instance, in April 2019, Lonza launches the newest in its portfolio of bioactive, H2OBioEV Bioactive, a multifunctional cosmetic ingredient that revitalizes, rejuvenates and moisturizes the skin. H2OBioEV Bioactive moisturizes by replenishing essential humectants, which offer an optimal environment for epidermal proteins to form and maintain a strong barrier, thus restoring a smooth and radiant appearance.
Food and Drug Administration (FDA)
Key players operating in the global bioactive protein and peptides are Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., Omega Protein Corporation, Bunge Ltd., E.I., Du Pont De Nemours and Company, Fonterra Co-operative Group Ltd., Royal DSM and CHS Inc.
Few Recent Developments
Fonterra Co-operative Group Ltd.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.